Contineum Therapeutics, Inc. — Investor Relations & Filings
Contineum Therapeutics is a clinical-stage biopharmaceutical company that discovers and develops novel, oral small molecule therapies for conditions at the intersection of neurology, inflammation, and immunology (NI&I). The company focuses on pioneering treatments that target clinically validated biological pathways to address diseases with limited therapeutic options. Its pipeline features multiple drug candidates in clinical trials. Key programs include a lysophosphatidic acid 1 (LPA1) receptor antagonist for idiopathic pulmonary fibrosis (IPF) and progressive multiple sclerosis (PrMS), and an M1 muscarinic receptor (M1R) antagonist for major depressive disorder (MDD), developed in collaboration with Janssen Pharmaceutica NV.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - Contineum Therapeutics, Inc. (0001855175) (Filer) | 2026-04-30 | English | |
| 8-K - Contineum Therapeutics, Inc. (0001855175) (Filer) | 2026-04-30 | English | |
| 4 - CONTINEUM THERAPEUTICS, INC. (0001855175) (Filer) | 2026-03-03 | English | |
| 4 - CONTINEUM THERAPEUTICS, INC. (0001855175) (Filer) | 2026-03-03 | English | |
| 4 - CONTINEUM THERAPEUTICS, INC. (0001855175) (Filer) | 2026-02-26 | English | |
| 4 - CONTINEUM THERAPEUTICS, INC. (0001855175) (Filer) | 2026-02-26 | English |
Browse filings by year
4 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Contineum Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33219/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33219 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33219 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33219 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33219}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Contineum Therapeutics, Inc. (id: 33219)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.